Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers | PLOS ONE
![SciELO - Brasil - Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo SciELO - Brasil - Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo](https://minio.scielo.br/documentstore/1806-3756/QytwY3bdQmckM7Z8zPypmSP/2c61e75018d54ce51fb990b6b1124136d5f9df4e.gif)
SciELO - Brasil - Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo
![Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-59031-1/MediaObjects/41598_2020_59031_Fig1_HTML.png)
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
![Differences of tumor markers between male lung cancer patients with and... | Download Scientific Diagram Differences of tumor markers between male lung cancer patients with and... | Download Scientific Diagram](https://www.researchgate.net/publication/339544771/figure/tbl1/AS:863359473823747@1582852347702/Differences-of-tumor-markers-between-male-lung-cancer-patients-with-and-without-OM.png)
Differences of tumor markers between male lung cancer patients with and... | Download Scientific Diagram
Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer | PLOS ONE
![PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer](https://www.researchgate.net/profile/Joachim-Pawel/publication/242354126/figure/tbl1/AS:393144983146496@1470744476082/Useful-and-potentially-useful-markers-for-lung-cancer_Q320.jpg)
PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer
Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer | PLOS ONE
![Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer - Palmer - Journal of Thoracic Disease Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer - Palmer - Journal of Thoracic Disease](https://cdn.amegroups.cn/journals/pbpc/files/journals/2/articles/2168/public/2168-PB5-R1.png/w300)
Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer - Palmer - Journal of Thoracic Disease
![Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1044579X17300974-gr2.jpg)
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect
![Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research](https://cdn.amegroups.cn/journals/pbpc/files/journals/5/articles/2729/public/2729-PB3-R1.png/w300)
Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research
![Table 4 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar Table 4 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9cbea13732ed9f9299e409d9fb7b272385d2ae69/7-Table4-1.png)
Table 4 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar
![Table 1 from Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE | Semantic Scholar Table 1 from Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8ca3c249142cbe1d4e92eefae11e9bfcb042c18c/3-Table1-1.png)
Table 1 from Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE | Semantic Scholar
![PDF] Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. | Semantic Scholar PDF] Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/75c7a5a10a62339b88fe5157b0ecc21dd7bfacd8/2-Table3-1.png)
PDF] Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. | Semantic Scholar
![PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer](https://www.researchgate.net/profile/Joachim-Pawel/publication/242354126/figure/tbl2/AS:393144983146497@1470744476106/Recommendations-for-use-of-markers-according-to-histologies-of-lung-cancer-and_Q320.jpg)